Pegylated Interferon Alpha-2a in 75 Patients with Myeloproliferative Neoplasms: A Single Center Experience

被引：0
|
作者：
Gowin, Krisstina L. [1 ]
Jain, Tania [1 ]
Kosiorek, Heidi E. [2 ]
Camoriano, John [1 ]
Tibes, Raoul [1 ]
Palmer, Jeanne [1 ]
Mesa, Ruben A. [1 ]
机构：
[1] Mayo Clin Arizona, Hematol Oncol, Scottsdale, AZ USA
[2] Mayo Clin, Scottsdale, AZ USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Pegylated Interferon Alpha-2a in Patients with Myeloproliferative Neoplasms (MPN): International Experience in 115 Cases
    Gowin, Krisstina
    Thapaliya, Prakash
    Samuelson, J.
    Harrison, C. N.
    Radia, Deepti
    Andreasson, Bjorn
    Mascarenhas, John
    Rambaldi, Alessandro
    Barbui, T.
    Rea, Catherine J.
    Camoriano, John
    Gentry, A.
    Kiladjian, Jean-Jacques
    O'Connell, Casey L.
    Mesa, Ruben A.
    [J]. BLOOD, 2011, 118 (21) : 1215 - 1215
  • [2] Single centre experience in the use of pegylated interferon alpha for myeloproliferative neoplasms
    Ruparelia, M.
    Loughran, C.
    Qureshi, H.
    Asagba, G.
    Garg, M.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 79 - 79
  • [3] Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience
    Alsaran, Khalid
    Sabry, Alaa
    Shaheen, Naila
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (03) : 865 - 873
  • [4] Pegylated interferon alpha-2a for treatment of chronic HCV infection in hemodialysis patients: a single Saudi center experience
    Khalid Alsaran
    Alaa Sabry
    Naila Shaheen
    [J]. International Urology and Nephrology, 2011, 43 : 865 - 873
  • [5] TREATMENT OF PATIENTS WITH PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS WITH PEGYLATED INTERFERON ALPHA-2A: A PROSPECTIVE MONOCENTER COHORT STUDY.
    Betti, S.
    Rossi, E.
    Za, T.
    Ciminello, A.
    De Ritis, D. G.
    Genovese, S.
    Annunziata, F.
    Marietti, S.
    Chiusolo, P.
    De Stefano, V.
    [J]. HAEMATOLOGICA, 2014, 99 : 132 - 132
  • [6] Pegylated interferon alpha-2a in high risk myeloproliferative neoplasms: A safe, effective and well tolerated alternative to hydroxycarbamide
    Garg, M.
    Ruparelia, M.
    Sachedina, S.
    Asagba, G.
    Krishna, R.
    Qureshi, H.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 136 - 136
  • [7] Comparison of the Efficacy and Safety of Pegylated Interferon Alpha-2b and Common Interferon Alpha in Patients with Myeloproliferative Neoplasms
    Teng, Guangshuai
    Zhang, Yuhui
    Du, Chenxiao
    Wang, Yan
    Hu, Naibo
    Han, Yingdi
    Ma, Jinyu
    Gao, Shan
    Xiang, Guangpeng
    Shao, Zonghong
    Bai, Jie
    [J]. BLOOD, 2022, 140 : 3959 - 3960
  • [8] Experience with pegylated interferon α-2a in advanced myeloproliferative neoplasms in an international cohort of 118 patients
    Gowin, Krisstina
    Thapaliya, Prakash
    Samuelson, Jan
    Harrison, Claire
    Radia, Deepti
    Andreasson, Bjorn
    Mascarenhas, John
    Rambaldi, Alessandro
    Barbui, Tiziano
    Rea, Catherine J.
    Camoriano, John
    Gentry, Amy
    Kiladjian, Jean-Jacques
    O'Connell, Casey
    Mesa, Ruben
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (10): : 1570 - 1573
  • [9] A real-world single-center retrospective study on efficacy and safety of pegylated interferon alpha-2a in epatients with myeloproliferative neoplasm.
    Ozcan, Muhit
    Koyun, Derya
    Seval, Guldane Cengiz
    Uslu, Atilla
    Kircali, Ekin
    Ozturk, Cemaleddin
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Topcuoglu, Pervin
    Arslan, Onder
    Ilhan, Osman
    Beksac, Meral
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Efficacy and Safety of Pegylated Interferon in Myeloproliferative Neoplasms - A Regional Experience
    Ryan, Eileen
    Houston, Conal
    McDonald, Laura
    Byrne, Niamh O'Connor
    Whyte, Maureen
    Kumar, Sentil
    Elhassadi, Ezzat
    Hennessy, Brian
    Clifford, Ruth
    Mykytiv, Vitaliy
    O'Shea, Derville
    Keohane, Clodagh
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 118 - 118
12345